European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
Community list of not active medicinal products for human use |
WITHDRAWN |
Product information |
| Invented name: | Indimacis 125 |
| Auth. number : | EU/1/96/025 |
| INN : | Igovomab |
| ATC: | V - Various V09 - Diagnostic radiopharmaceuticals V09I - Tumour detection V09IB - Indium (111In) compounds V09IB03 - Indium (111In) antiovariumcarcinoma antibody (See WHO ATC Index) |
| Indication: | Diagnosis of ovarian adenocarcinoma |
| Marketing Authorisation Holder: | CIS bio international
route Nationale 306, Saclay, Boite Postale 32, F-91192 Gif-sur-Yvette, France |
EPAR and active package presentations
Package presentations
|
The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information". Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register. |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 10/10/1996 | Centralised - Authorisation | EMEA/H/C/65 | (96)2725 of 04/10/1996 | |||
| 02/10/1997 | Centralised - Variation | EMEA/H/C/65/N/2 | (97)2949 of 01/10/1997 | |||
| 30/09/1999 | Centralised - Withdrawal | - | (1999)2962 of 14/09/1999 |